BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fiocchi C, Ina K, Danese S, Leite AZA, Vogel JD. Alterations of Mesenchymal and Endothelial Cells in Inflammatory Bowel Diseases. In: Blumberg RS, Neurath MF, editors. Immune Mechanisms in Inflammatory Bowel Disease. New York: Springer; 2006. pp. 168-76. [DOI: 10.1007/0-387-33778-4_11] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
Number Citing Articles
1 Borensztajn K, Peppelenbosch MP, Spek CA. Coagulation factor Xa signaling: the link between coagulation and inflammatory bowel disease? Trends in Pharmacological Sciences 2009;30:8-16. [DOI: 10.1016/j.tips.2008.10.007] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
2 Danese S. Mechanisms of action of infliximab in inflammatory bowel disease: an anti-inflammatory multitasker. Dig Liver Dis. 2008;40 Suppl 2:S225-S228. [PMID: 18598993 DOI: 10.1016/s1590-8658(08)60530-7] [Cited by in Crossref: 43] [Cited by in F6Publishing: 22] [Article Influence: 3.1] [Reference Citation Analysis]
3 Hayashi Y, Tsuji S, Tsujii M, Nishida T, Ishii S, Iijima H, Nakamura T, Eguchi H, Miyoshi E, Hayashi N, Kawano S. Topical Implantation of Mesenchymal Stem Cells Has Beneficial Effects on Healing of Experimental Colitis in Rats. J Pharmacol Exp Ther 2008;326:523-31. [DOI: 10.1124/jpet.108.137083] [Cited by in Crossref: 88] [Cited by in F6Publishing: 86] [Article Influence: 6.3] [Reference Citation Analysis]
4 Mahida YR, Moran GW. Do non-immune cells have a role in IBD? Inflamm Bowel Dis 2008;14 Suppl 2:S123-4. [PMID: 18816764 DOI: 10.1002/ibd.20680] [Reference Citation Analysis]
5 Powell DW, Pinchuk IV, Saada JI, Chen X, Mifflin RC. Mesenchymal cells of the intestinal lamina propria. Annu Rev Physiol. 2011;73:213-237. [PMID: 21054163 DOI: 10.1146/annurev.physiol.70.113006.100646] [Cited by in Crossref: 221] [Cited by in F6Publishing: 205] [Article Influence: 20.1] [Reference Citation Analysis]
6 Actis GC, Pellicano R, Rizzetto M, Ayoubi M, Leone N, Tappero G, Pazienza P, Rosina F. Individually administered or co-prescribed thiopurines and mesalamines for inflammatory bowel disease. World J Gastroenterol 2009; 15(12): 1420-1426 [PMID: 19322913 DOI: 10.3748/wjg.15.1420] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
7 Hornby PJ. Drug discovery approaches to irritable bowel syndrome. Expert Opinion on Drug Discovery 2015;10:809-24. [DOI: 10.1517/17460441.2015.1049528] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
8 Dryden GW Jr. Overview of biologic therapy for Crohn's disease. Expert Opin Biol Ther 2009;9:967-74. [PMID: 19591627 DOI: 10.1517/14712590903048909] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
9 Lund PK, Rigby RJ. What are the mechanisms of fibrosis in IBD? Inflamm Bowel Dis 2008;14 Suppl 2:S127-8. [PMID: 18816738 DOI: 10.1002/ibd.20681] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
10 Latella G, Fiocchi C, Caprilli R. Late-breaking news from the "4th International Meeting on Inflammatory Bowel Diseases" Capri, 2006. Inflamm Bowel Dis 2007;13:1031-50. [PMID: 17309072 DOI: 10.1002/ibd.20127] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
11 Danese S. Nonimmune cells in inflammatory bowel disease: from victim to villain. Trends Immunol. 2008;29:555-564. [PMID: 18838297 DOI: 10.1016/j.it.2008.07.009] [Cited by in Crossref: 31] [Cited by in F6Publishing: 36] [Article Influence: 2.4] [Reference Citation Analysis]
12 Lanzoni G, Alviano F, Marchionni C, Bonsi L, Costa R, Foroni L, Roda G, Belluzzi A, Caponi A, Ricci F, Luigi Tazzari P, Pagliaro P, Rizzo R, Lanza F, Roberto Baricordi O, Pasquinelli G, Roda E, Paolo Bagnara G. Isolation of stem cell populations with trophic and immunoregulatory functions from human intestinal tissues: potential for cell therapy in inflammatory bowel disease. Cytotherapy 2009;11:1020-31. [PMID: 19929466 DOI: 10.3109/14653240903253840] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 2.5] [Reference Citation Analysis]
13 Caetano AJ, Yianni V, Volponi A, Booth V, D'Agostino EM, Sharpe P. Defining human mesenchymal and epithelial heterogeneity in response to oral inflammatory disease. Elife 2021;10:e62810. [PMID: 33393902 DOI: 10.7554/eLife.62810] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]